Suresh Acharya, Professor of Practice at the University of Maryland’s Robert H. Smith School of Business, lays out the challenges of creating an end-to-end supply chain that can produce and distribute millions of doses of a vaccine for COVID-19.

Theo Smid, economist with trade credit insurer Atradius, discusses the results of the firm’s recent forecast of corporate insolvencies for 2020.

Rosemary Coates, executive director of The Reshoring Institute, explains why the coronavirus pandemic might finally be the crisis that drives manufacturers to shift production from China back to the U.S.

Patrick Thielen, senior vice president of financial lines with Chubb, explains why malware attacks are on the rise, and what manufacturers must do to protect their people and systems from cyber criminals.

Ann Marie Uetz, head of the coronavirus task force with the law firm of Foley & Lardner LLP, discusses the results of a pair of surveys about how executives are responding to supply-chain disruptions caused by the pandemic and rising geopolitical tensions.

Rob Wilson, president of Employco USA, offers advice on how employers should protect workers from contracting the coronavirus in the workplace, and what action to take when they do.

Jeff Livingston, senior solutions consultant with QAD DynaSys, explains the importance of resilience in the supply-chain function, in times of high demand variability and uncertainty.

Alexa Driansky, senior vice president in the retail practice of AlixPartners, discusses the findings of the firm’s latest forecast for retail holiday sales in the U.S.

Robert Eubanks, director of healthcare and life sciences with West Monroe, discuses the changes in how vaccines and drug therapies are developed and distributed as a result of the COVID-19 pandemic.

Noha Tohamy, Distinguished Vice President of Research with Gartner, discusses the findings of the firm’s latest Hype Cycle for assessing technology maturity.